Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. Its product, DeepView System, uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely and informed decision regarding the treatment of the patient’s wounds. The company’s system also includes MSI imaging technology, a proprietary multi-spectral optics and sensors, capturing injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.